標靶定序和標靶定序市場規模、佔有率和成長分析：按定序方法、產品、應用、最終用戶和地區分類 - 產業預測，2026-2033年

2024 年全球標靶定序和標靶定序市場價值為 55.2 億美元，預計到 2033 年將從 2025 年的 61.6 億美元成長至 148.5 億美元，在預測期（2026-2033 年）內複合年成長率為 11.52%。

受精準醫療領域對具成本效益、高通量解決方案的需求驅動，全球標靶定序和標靶定序市場正經歷顯著成長。標靶定序專注於特定的基因組區域，在降低資料量的同時提高靈敏度；而定序識別相對於參考基因組的突變。與傳統的全基因測序相比，這兩種方法都能使臨床醫生和研究人員更快、更經濟地獲得基因組數據。次世代定序技術的進步正在降低成本，並加速其在臨床工作流程中的廣泛應用和整合。因此，製造商正在擴展其檢測產品線，以滿足對快速突變檢測日益成長的需求。值得關注的應用包括液態生物檢體和病原體定序，可以預見，基因組分析這一關鍵領域的投資和創新將會持續成長。

全球標靶定序與標靶定序市場促進因素

定序技術的進步顯著提高了準確性、速度和柔軟性，使檢查室負責人能夠更輕鬆地針對特定基因組區域。這些技術進步降低了使用標靶定序平台的門檻，使服務提供者能夠開發針對臨床或研究目標的客製化檢測方法，從而拓展了標靶定序和標靶定序的應用範圍。此外，創新儀器和試劑的出現也提高了工作流程的整合性，並增強了與下游分析的兼容性。這些發展促使診斷檢查室、生物技術公司和學術機構擴大採用標靶定序和標靶重測序技術，共同推動了全球標靶定序和標靶重定序市場的成長。

全球標靶定序與標靶定序市場的限制因素

資金限制使得小規模臨床檢查室和研究機構難以採用先進的定序技術和必要的基礎設施。當預算優先用於維持現有營運時，關鍵決策者可能會推遲甚至放棄對標靶定序平台的投資，導致製造商的潛在基本客群萎縮。這種情況可能導致需求集中在中心化實驗室和服務供應商之間，從而降低標靶定序市場的分散程度。這種轉變最終將減緩院內檢測能力的普及，並減緩標靶定序和標靶定序市場的整體成長。

全球標靶定序與標靶定序市場趨勢

全球標靶定序和標靶定序市場正呈現與臨床診斷顯著融合的趨勢，加速了其在醫療機構的應用。在檢查室中，標靶檢測在診斷流程中的日益普及，正在改善治療方法的選擇、疾病監測和早期發現。這一趨勢的促進因素包括檢體處理的標準化、報告時間的縮短以及檢查室人員與醫療服務提供者之間協作的加強，所有這些因素都有助於提高檢測的臨床效用。隨著支持標靶檢測有效性的證據不斷積累，健康保險公司和醫療服務提供者開始認知到其在個人化醫療中的價值，從而加大對檢驗、品管和臨床醫生培訓的投入，以實現有效實施。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球標靶定序與標靶定序市場規模：按定序方法分類

• 基於擴增子的定序
• 雜合反應捕獲
• 全EXOME定序
• RNA定序

全球標靶定序與標靶定序市場規模：按產品類別分類

• 裝置
• 試劑和試劑盒
• 軟體

全球標靶定序與標靶定序市場規模：按應用領域分類

• 腫瘤學
• 遺傳性疾病
• 感染疾病
• 藥物基因體學

全球靶向定序和靶向定序市場規模：按最終用戶分類

• 製藥和生物技術
• 臨床檢查室
• 學術研究

全球標靶定序與標靶定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina Inc.
• Thermo Fisher Scientific
• Qiagen NV
• Agilent Technologies
• Roche
• Pacific Biosciences
• Oxford Nanopore Technologies
• BGI Genomics
• Twist Bioscience
• Integrated DNA Technologies（IDT）
• Genoptix（Novartis）
• Foundation Medicine（Roche）
• Guardant Health
• Tempus Labs
• Grail Inc.

結論與建議

Global Targeted Sequencing And Resequencing Market size was valued at USD 5.52 Billion in 2024 and is poised to grow from USD 6.16 Billion in 2025 to USD 14.85 Billion by 2033, growing at a CAGR of 11.52% during the forecast period (2026-2033).

The global market for targeted sequencing and resequencing is experiencing significant growth, driven by the demand for cost-effective, high-throughput solutions in Precision Medicine. Targeted sequencing focuses on specific genomic areas, offering enhanced sensitivity with reduced data volume, while resequencing identifies variations against reference genomes. Both approaches enable clinicians and researchers to access faster, more economical genomic data than traditional whole-genome sequencing methods. Advances in next-generation sequencing technologies have lowered costs, facilitating widespread adoption and integration into clinical workflows. As a result, manufacturers are expanding their assay offerings to meet the rising demand for rapid mutation detection. Notable applications include liquid biopsies for cancer monitoring and pathogen resequencing, ensuring increased investment and innovation in this critical field of genomic analysis.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Targeted Sequencing And Resequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Targeted Sequencing And Resequencing Market Segments Analysis

Global targeted sequencing and resequencing market is segmented by sequencing method, product, application, end-user and region. Based on sequencing method, the market is segmented into Amplicon-Based Sequencing, Hybridization Capture, Whole Exome Sequencing and RNA Sequencing. Based on product, the market is segmented into Instruments, Reagents & Kits and Software. Based on application, the market is segmented into Oncology, Inherited Diseases, Infectious Disease and Pharmacogenomics. Based on end-user, the market is segmented into Pharma & Biotech, Clinical Labs and Academic Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Targeted Sequencing And Resequencing Market

Advancements in sequence generation technologies have significantly enhanced their accuracy, speed, and flexibility, enabling laboratory personnel to easily target specific genomic regions. These technological enhancements have lowered the barriers to using targeted panels and empowered providers to develop assays tailored to their clinical or research objectives, thus broadening the range of applications for targeted sequencing and resequencing. Moreover, the launch of innovative instruments and chemistries has facilitated improved workflow integration and compatibility with downstream analyses. This progression contributes to increased adoption by diagnostic laboratories, biotechnology firms, and academic institutions, collectively driving growth in the Global Targeted Sequencing and Resequencing market.

Restraints in the Global Targeted Sequencing And Resequencing Market

Financial limitations on advanced sequencing technologies and their necessary infrastructures can hinder smaller clinical labs and research institutions from adopting these tools. When budgetary priorities focus on current operations, key decision-makers may delay or opt against investing in targeted sequencing platforms, which diminishes the potential customer base for manufacturers. Consequently, this scenario could lead to a consolidation of demand towards centralized testing facilities or service providers, resulting in a less fragmented market for targeted sequencing. This shift ultimately slows the adoption of in-house testing capabilities, causing the overall growth of the targeted sequencing and resequencing market to decelerate.

Market Trends of the Global Targeted Sequencing And Resequencing Market

The Global Targeted Sequencing and Resequencing market is witnessing a significant trend towards integration with clinical diagnostics, driving its adoption across healthcare settings. Laboratories increasingly utilize targeted panels within diagnostic testing workflows, enhancing therapy selection, disease monitoring, and early detection. This movement is bolstered by standardization in sample processing, faster reporting times, and improved collaboration between laboratory staff and healthcare providers, which collectively heighten the clinical utility of assays. As the evidence supporting the efficacy of targeted assays mounts, healthcare payers and providers are beginning to recognize their value in personalized medicine, thereby prompting greater investment in validation, quality management, and clinician education for effective implementation.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Targeted Sequencing And Resequencing Market Size by Sequencing Method & CAGR (2026-2033)

• Market Overview
• Amplicon-Based Sequencing
• Hybridization Capture
• Whole Exome Sequencing
• RNA Sequencing

Global Targeted Sequencing And Resequencing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Software

Global Targeted Sequencing And Resequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Inherited Diseases
• Infectious Disease
• Pharmacogenomics

Global Targeted Sequencing And Resequencing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma & Biotech
• Clinical Labs
• Academic Research

Global Targeted Sequencing And Resequencing Market Size & CAGR (2026-2033)

• North America (Sequencing Method, Product, Application, End-User)
  • US
  • Canada
• Europe (Sequencing Method, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Sequencing Method, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Sequencing Method, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Sequencing Method, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoptix (Novartis)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine (Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grail Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations